Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital  —  Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.


© 2002-2016 Все права защищены. Хостинг предоставлен Adelinahost.  Lyrics provided by Lyrics A-z, Az lyrics and Azlyrics.Com.Az.